A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Atopic Dermatitis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Leo Pharma Investigational site, Birmingham, Alabama, United States

  • Leo Pharma Investigational site, North Little Rock, Arkansas, United States

  • Leo Pharma Investigational site, Palo Alto, California, United States

  • Leo Pharma Investigational site, Sacramento, California, United States

  • Leo Pharma Investigational site, San Diego, California, United States

  • Leo Pharma Investigational site, San Diego, California, United States

  • Leo Pharma Investigational site, Jacksonville, Florida, United States

  • Leo Pharma Investigational site, Miami, Florida, United States

  • Leo Pharma Investigational site, Tampa, Florida, United States

  • Leo Pharma Investigational site, Macon, Georgia, United States

  • Leo Pharma Investigational site, Waterford, Michigan, United States

  • Leo Pharma Investigational site, Tulsa, Oklahoma, United States

  • Leo Pharma Investigational site, Portland, Oregon, United States

  • Leo Pharma Investigational site, Charleston, South Carolina, United States

  • Leo Pharma Investigational site, Norfolk, Virginia, United States

  • Leo Pharma Investigational site, Brussels, Belgium

  • Leo Pharma Investigational site, Ghent, Belgium

  • Leo Pharma Investigational site, Leuven, Belgium

  • Leo Pharma Investigational site, Liège, Belgium

  • Leo Pharma Investigational site, Burlington, Canada

  • Leo Pharma Investigational site, Calgary, Canada

  • Leo Pharma Investigational site, Calgary, Canada

  • Leo Pharma Investigational site, Edmonton, Canada

  • Leo Pharma Investigational site, Edmonton, Canada

  • Leo Pharma Investigational site, Hamilton, Canada

  • Leo Pharma Investigational site, Niagara Falls, Canada

  • Leo Pharma Investigational site, Saskatoon, Canada

  • Leo Pharma Investigational site, Windsor, Canada

  • Leo Pharma Investigational site, Winnipeg, Canada

  • Leo Pharma Investigational site, Rijeka, Croatia

  • Leo Pharma Investigational site, Zagreb, Croatia

  • Leo Pharma Investigational site, Zagreb, Croatia

  • Leo Pharma Investigational site, Buxtehude, Germany

  • Leo Pharma Investigational site, Dresden, Germany

  • Leo Pharma Investigational site, Mainz, Germany

  • Leo Pharma Investigational site, Osnabrück, Germany

  • Leo Pharma Investigational site, Tübingen, Germany

  • Leo Pharma Investigational site, Wuppertal, Germany

  • Leo Pharma Investigational site, Cork, Ireland

  • Leo Pharma Investigational site, Crumlin, Ireland

  • Leo Pharma Investigational site, Ancona, Italy

  • Leo Pharma Investigational site, Brescia, Italy

  • Leo Pharma Investigational site, Padova, Italy

  • Leo Pharma Investigational site, Roma, Italy

  • Leo Pharma Investigational site, Rome, Italy

  • Leo Pharma Investigational site, Utrecht, Netherlands

  • Leo Pharma Investigational site, Gdansk, Poland

  • Leo Pharma Investigational site, Krakow, Poland

  • Leo Pharma Investigational site, Lodz, Poland

  • Leo Pharma Investigational site, Ostrowiec Świętokrzyski, Poland

  • Leo Pharma Investigational site, Rzeszów, Poland

  • Leo Pharma Investigational site, Tarnów, Poland

  • Leo Pharma Investigational site, Warsaw, Poland

  • Leo Pharma Investigational site, Warsaw, Poland

  • Leo Pharma Investigational site, Brasov, Romania

  • Leo Pharma Investigational site, Iași, Romania

  • Leo Pharma Investigational site, Ansan-si, South Korea

  • Leo Pharma Investigational site, Gwangju, South Korea

  • Leo Pharma Investigational site, Seoul, South Korea

  • Leo Pharma Investigational site, Seoul, South Korea

  • Leo Pharma Investigational site, Seoul, South Korea

  • Leo Pharma Investigational site, Seoul, South Korea

  • Leo Pharma Investigational site, Seoul, South Korea

  • Leo Pharma Investigational site, Seoul, South Korea

  • Leo Pharma Investigational site, Seoul, South Korea

  • Leo Pharma Investigational site, Alicante, Spain

  • Leo Pharma Investigational site, Madrid, Spain

  • Leo Pharma Investigational site, Valencia, Spain

  • Leo Pharma Investigational site, Lincoln, United Kingdom

  • Leo Pharma Investigational site, London, United Kingdom

  • Leo Pharma Investigational site, Sheffield, United Kingdom

  • Leo Pharma Investigational site, Southampton, United Kingdom

מובילי המחקר
  • Medical Expert

    Study Director

    LEO Pharma